Results 61 to 70 of about 19,340 (214)

Predicting the recombination potential of severe acute respiratory syndrome coronavirus 2 and Middle East respiratory syndrome coronavirus [PDF]

Journal of General Virology, 2020
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently emerged to cause widespread infections in humans. SARS-CoV-2 infections have been reported in the Kingdom of Saudi Arabia, where Middle East respiratory syndrome coronavirus (MERS-CoV) causes seasonal outbreaks with a case fatality rate of ~37 %.
Banerjee, Arinjay, Doxey, Andrew C., Tremblay, Benjamin J.-M., Mansfield, Michael J., Subudhi, Sonu, Hirota, Jeremy A., Miller, Matthew S., McArthur, Andrew G., Mubareka, Samira, Mossman, Karen   +9 more
openaire   +2 more sources

Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Coronavirus disease 2019 (COVID‐19) is an infectious disease caused by severe acute respiratory syndrome coronavirus‐2, which has posed a significant threat to global health.
Luis Ortega‐Paz, Davide Capodanno, Gilles Montalescot, Dominick J. Angiolillo   +3 more
doaj   +1 more source

Early Introduction of Severe Acute Respiratory Syndrome Coronavirus 2 into Europe [PDF]

Emerging Infectious Diseases, 2020
Early infections with severe acute respiratory syndrome coronavirus 2 in Europe were detected in travelers from Wuhan, China, in January 2020. In 1 tour group, 5 of 30 members were ill; 3 cases were laboratory confirmed. In addition, a healthcare worker was infected. This event documents early importation and subsequent spread of the virus in Europe.
Sonja J. Olsen, Meng-Yu Chen, Yu-Lun Liu, Mark Witschi, Alexis Ardoin, Clémentine Calba, Pauline Mathieu, Virginie Masserey, Francesco Maraglino, Stefano Marro, Pasi Penttinen, Emmanuel Robesyn, Jukka Pukkila   +12 more
openaire   +3 more sources

Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium

Journal of Virology, 2020
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged by the end of 2019 and rapidly spread in 2020. At present, it is of utmost importance to understand the biology of the virus, rapidly assess the treatment potential of existing drugs, and develop new active compounds.
Milewska, Aleksandra, Kula-Pacurar, Anna, Wadas, Jakub, Suder, Agnieszka, Szczepanski, Artur, Dabrowska, Agnieszka, Owczarek, Katarzyna, Marcello, Alessandro, Ochman, Marek, Stacel, Tomasz, Rajfur, Zenon, Sanak, Marek, Labaj, Pawel, Branicki, Wojciech, Pyrc, Krzysztof   +14 more
openaire   +5 more sources

Acute Myocarditis After Severe Acute Respiratory Syndrome Coronavirus 2 Infection

The Journal for Nurse Practitioners, 2023
This case report describes a young adult patient with post-severe acute respiratory syndrome coronavirus 2 acute viral myocarditis who initially presented to a local urgent care center. The patient decompensated and was transferred to our tertiary, intensive care setting.
LaJoie, Joan, Lentz, Brian
openaire   +2 more sources

Phosphatidylinositol 4‐kinase as a target of pathogens—friend or foe?

FEBS Letters, EarlyView.
This graphical summary illustrates the roles of phosphatidylinositol 4‐kinases (PI4Ks). PI4Ks regulate key cellular processes and can be hijacked by pathogens, such as viruses, bacteria and parasites, to support their intracellular replication. Their dual role as essential host enzymes and pathogen cofactors makes them promising drug targets.
Ana C. Mendes, Guilherme M. Azevedo, Amanda P. Barcellos, Diana Bahia   +3 more
wiley   +1 more source

Symptomatic severe acute respiratory syndrome coronavirus 2 reinfection in a lupus patient treated with hydroxychloroquine: a case report

Journal of Medical Case Reports, 2021
Background Hydroxychloroquine and chloroquine have been used for hospitalized coronavirus disease 2019 patients because of their antiviral and anti-inflammatory function.
Astrid Muyldermans, Piet Maes, Tony Wawina-Bokalanga, Tine Anthierens, Olivier Goldberg, Magali Bartiaux, Oriane Soetens, Ingrid Wybo, Sigi Van den Wijngaert, Denis Piérard   +9 more
doaj   +1 more source

Delivery of DNA‐encoded vaccines and proteins in mice using cutaneous suction‐mediated transfection

FEBS Open Bio, EarlyView.
Cutaneous suction‐mediated transfection in mice for delivery of DNA‐encoded vaccines and proteins. A critical limitation of DNA vaccines and other therapeutics is transfection in vivo to produce the encoded antigens or therapeutic proteins. Cutaneous suction‐based methods have demonstrated effectiveness in many animal models and have been successfully ...
Emran O. Lallow, Isabel Brandtjen, Yaxin Mo, Melissa Gulley, Louis Osorio, Sagar Kudchodkar, Nandita C. Jhumur, Christine C. Roberts, Lisa K. Denzin, David I. Shreiber, Biju Parekkadan, Hao Lin, Joel N. Maslow   +12 more
wiley   +1 more source

RETRACTION: Top 100 cited articles on anosmia and COVID‐19: a bibliometric analysis

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView., 2023
Retraction: Tan, DJY, Ko, TK. Top 100 cited articles on anosmia and COVID‐19: a bibliometric analysis. World J Otorhinolaryngol Head Neck Surg. 2023; 1–8. doi:10.1002/wjo2.125. The above article, published online on 28 July 2023 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal's Editor ...
Denise Jia Yun Tan, Tsz Ki Ko
wiley   +1 more source

Undocumented Migrants Reintroducing COVID-19, Yunnan Province, China

Emerging Infectious Diseases, 2021
To limit the spread of severe acute respiratory syndrome coronavirus 2, the government of China has been monitoring infected travelers and minimizing cold-chain contamination. However, other factors might contribute to recurring outbreaks. We analyze the
Meiling Zhang, Jienan Zhou, Senquan Jia, Xiaonan Zhao, Yaoyao Chen, Yanhong Sun, Zhaosheng Liu, Xiaofang Zhou, Duo Li, Chunrui Luo, Yong Zhang, Violet Magoma Onsongo, Yong Shao, Xiaoqing Fu   +13 more
doaj   +1 more source